Status:

COMPLETED

Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP)

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

Fondation Université de Paris

Fondation Hôpitaux de Paris-Hôpitaux de France

Conditions:

COVID-19

Eligibility:

All Genders

18+ years

Brief Summary

The objective of the COVID-HOP study is to identify biological and non-biological markers associated to: a positive or negative serology anti SRAS-Cov-2; a positive serology and having presented sympt...

Detailed Description

To answer the questions raised in the primary and secondary endpoints, a biological collection (serum, plasma, DNA, RNA, mono-nucleated cells and urine) and a collection of detailed data by the mean o...

Eligibility Criteria

Inclusion

  • Hospital staff (medical and non-medical)
  • Age greater than or equal to 18 years
  • Benefiting from or having benefited 6 months ago from carrying out a SARS-CoV-2 serology by venous sampling on a APHP site as part of monitoring by a screening center
  • Having been informed about the study and having given their informed consent to participate in the study
  • Beneficiary or entitled to a social security scheme

Exclusion

  • Refusal to participate in the study
  • Previously known anemia with hemoglobin \<10 g / dL
  • Subject already included in a cohort study with biological collection COVID-19
  • Exclusion period for subjects included or having been included in a COVID-19 interventional study (prophylactic or curative) or other clinical study
  • Subject who received blinded treatment for SARS-Cov-2 in a clinical study
  • Recent COVID-19 compatible infection with D0 of symptoms less than 4 weeks before collection
  • Subject subject to a judicial protection measure
  • Subject under guardianship or curatorship
  • Subject under state medical aid

Key Trial Info

Start Date :

June 8 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 8 2022

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT04418375

Start Date

June 8 2020

End Date

October 8 2022

Last Update

May 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

HEGP

Paris, France